01
Dec
2008
Expression Genetics, Inc.: Series B $12M
Posted in I - Series B, Q - 3Q08, R - SOUTH EAST, X - Cardiology, X - Oncology, X - RNAi
Expression Genetics (Huntsville, AL) development-stage specialty biopharmaceutical company specializing in cancer immunotherapies for ovarian and cardiovascular disease, closed a $12M Series B financing. Participants include ?
OnBioVC PARTNERS
-
